@prefix this: . @prefix sub: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-gda: . @prefix dgn-void: . sub:head { this: np:hasAssertion sub:assertion ; np:hasProvenance sub:provenance ; np:hasPublicationInfo sub:publicationInfo ; a np:Nanopublication . } sub:assertion { dgn-gda:DGN34d174ebade38ea5def253a24b4e83ce sio:SIO_000628 miriam-gene:623 , lld:C0011875 ; a sio:SIO_001121 . } sub:provenance { sub:assertion dcterms:description "[These results showed that the inducible bradykinin B(1) receptor subtype participates in the modulation of the vascular permeability in diabetic rats and suggest that selective bradykinin B(1) receptor antagonism could have a beneficial role in reducing diabetic vascular complications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ; wi:evidence dgn-void:source_evidence_predicted ; sio:SIO_000772 miriam-pubmed:15878326 ; prov:wasDerivedFrom dgn-void:RGD ; prov:wasGeneratedBy eco:ECO_0000218 . dgn-void:RGD pav:importedOn "2017-01-25"^^xsd:date . dgn-void:source_evidence_predicted a eco:ECO_0000266 ; rdfs:comment "Gene-disease associations inferred from animal model manually asserted gene-disease associations."@en ; rdfs:label "DisGeNET evidence - PREDICTED"@en . } sub:publicationInfo { this: dcterms:created "2017-10-17T13:10:55+02:00"^^xsd:dateTime ; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup ; dcterms:subject sio:SIO_000983 ; prv:usedData dgn-void:disgenetv3.0rdf ; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v5.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v5.0.0" . }